NEXTBIOMEDICAL CO., LDT, announced that clinical study results of Nexsphere-F™, a resorbable embolic agent for treating joint pain, have been published in the esteemed Journal of Vascular and ...

Instylla, Inc. announced that it recently submitted the final module of its premarket approval (PMA) application to the FDA ...

In this final PMA module, Instylla has submitted clinical study resultsto the FDA, advancing our pursuit of the indication ...

There are lots of interesting companies that make Bedford their home. Below is a quick recap of what’s happening around town ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bwcc18605 ...

The global interventional cardiology devices market is on a strong growth trajectory, with a projected Compound Annual Growth ...

Background Onyx is frequently used for endovascular embolization of intracranial arteriovenous malformations (AVMs) and dural arteriovenous fistulas (dAVFs). One drawback of using Onyx is the ...

Data were included for 6,278 dentate participants without a prior history of stroke and 6,108 without prior AF who were followed over a 25-year period. The researchers found that 65 percent of the ...

The embolic protection devices market is growing, driven by rising cardiovascular procedures, technological advancements, and increasing focus on patient safety and ...

Nature Research Intelligence Topics enable transformational understanding and discovery in research by categorising any document into meaningful, accessible topics. Read this blog to understand ...